Pura Vida Investments
Tae-Il is a Medical Technology Analyst at Pura Vida. His areas of focus include medical devices, life sciences tools and diagnostics, healthcare IT, and managed care. Prior to joining in 2018, he was a Senior Associate at Baring Private Equity Asia, one of the largest private alternative investment firms in Asia. He started his career as an Analyst at Citigroup’s Asia TMT team in its global investment banking division. Tae-Il received a B.A. in Economics and International Relations, with minor in Mathematics, from University of Pennsylvania and an M.B.A. from Columbia Business School.
Pura Vida Investments
Pura Vida is a healthcare-focused hedge fund with a market-neutral approach. Since inception, the firm has generated superior returns and was named Best Emerging Manager in Global Equities by Absolute Return in 2018. Pura Vida invests across the healthcare space, including medical technology and devices, biotechnology, pharmaceuticals, healthcare services, as well as the legal cannabis space.